Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06115642Enrolling by invitationPhase 1
Study of HLX43 for advanced solid tumors
This trial tests a new drug called HLX43 for people with advanced or metastatic solid tumors that have not responded to standard treatments. It aims to find safe dosing and understand how the drug works in the body.
Stanford, CaliforniaAges 18–75 - NCT07231419RecruitingPhase 3
Study of suzetrigine for diabetic nerve pain
This trial tests an experimental pain drug called suzetrigine for people with diabetic peripheral neuropathy (nerve damage from diabetes that causes pain in the feet and legs). It aims to see if the drug can safely reduce pain over time.
Birmingham, AlabamaAges 18–80 - NCT07227116Recruiting
Finding transferable embryos in complex aneuploidy cases
This study aims to check if embryos previously considered too abnormal (with three or more chromosomal issues) might actually be usable for transfer. It may offer new options for patients who have only these types of embryos available.
Margate, FloridaAges Any age - NCT06837415Enrolling by invitation
Does Pre-Surgery Anxiety Relate to Blood Eosinophil Levels?
This study looks at whether how anxious people feel before surgery is linked to a type of white blood cell called an eosinophil. If you have a planned surgery, they will check your anxiety level and take a blood sample to see if there's a connection.
IstanbulAges 16–85 - NCT06597097Enrolling by invitation
Study of healthcare team collaboration with medical cannabis
This study looks at how healthcare professionals work together – between primary care doctors, hospital doctors, and pharmacists – during France’s medical cannabis experiment. It aims to see if teamwork improves care.
BrestAges 18 years+ - NCT07223229RecruitingPhase 2
Testing EI-001 for vitiligo that hasn't improved with other treatments
This study tests a new drug called EI-001 for people with non-segmental vitiligo (a type where white patches appear on both sides of the body). It is for those whose vitiligo has not gotten better with standard treatments like creams or light therapy, or who cannot use those treatments.
Huntington Beach, CaliforniaAges 18–65 - NCT06528535Recruiting
Food safety help for pregnant women in French Guiana
This study looks at a program to help pregnant women in French Guiana learn about food safety. If you join, you may receive extra information or support to keep you and your baby healthy.
CayenneAges Any age - NCT07217964Enrolling by invitation
Study of natural protein for spinal fusion surgery
This trial is testing a natural protein material used during spinal fusion surgery to treat lower back pain caused by worn-out discs. It may help patients who haven't gotten better with other treatments and need surgery on up to four levels of the lower spine.
New York, New YorkAges 18 years+ - NCT06531499RecruitingPhase 1
Study of a radioactive drug for advanced prostate cancer
This trial tests an extended treatment with a radioactive drug (177Lu-PSMA-617) to see how the body handles it, how safe it is, and how well it works. It is for men with metastatic castration-resistant prostate cancer who have not had chemotherapy yet.
Los Angeles, CaliforniaAges 18–100 - NCT07215975Recruiting
Luspatercept for adults with transfusion-dependent beta-thalassemia
This study looks at how well a medication called Luspatercept works for adults with transfusion-dependent beta-thalassemia, a blood condition that requires regular blood transfusions. Researchers want to understand how it helps people in the Middle East.
Seeb, Muḩāfaz̧at MasqaţAges 18 years+ - NCT06446414Enrolling by invitation
Provincial Scale-Up of Choose to Move Program
This trial looks at how well the Choose to Move (CTM) program works when it is expanded across a province. Researchers want to see if it helps older adults stay active and whether the program is being delivered as planned.
Vancouver, British ColumbiaAges 50 years+ - NCT06839807Recruiting
Testing a new device for knee replacement loosening
This study tests a new device (AtMoves Knee System) to help diagnose if a knee replacement is loose. It is for people who have had a knee replacement and have symptoms that might mean the implant is loose, but standard tests have not given a clear answer.
Nijmegen, GelderlandAges 18 years+ - NCT04877288RecruitingPhase 3
Switch some teen kidney transplant patients to belatacept
This Phase 3 study tests whether switching teens from one anti-rejection medicine to belatacept works as well as staying on the current regimen. It also looks at safety and whether patients can stay on their anti-rejection medicines.
Birmingham, AlabamaAges 12–17 - NCT06629233Enrolling by invitation
New immunotherapy targets for estrogen-receptor positive breast cancer
This trial tests a new technique to find unique targets on breast cancer cells that could be used for future immunotherapies. It focuses on women with estrogen-receptor positive primary breast cancer.
Ghent, East-FlandersAges 18 years+ - NCT07209501Enrolling by invitation
Aromatherapy for stem cell transplant patients
This trial tests if inhaling essential oils can help patients who are having a stem cell transplant after high-dose chemotherapy. It aims to see if this is a feasible and acceptable way to feel better during treatment.
SingaporeAges 21–99 - NCT07468110Recruiting
Nutrition and balance in chronic stroke survivors
This study looks at how a simple blood test (the CONUT score, which measures nutrition and immune health) relates to balance and daily function in people who have had a stroke a long time ago. It may help find ways to improve recovery and quality of life.
Istanbul, PendikAges 18–85 - NCT06804811RecruitingPhase 3
Ruxolitinib cream for children with vitiligo
This study tests whether a cream called ruxolitinib can help children ages 6 to 11 with nonsegmental vitiligo. It aims to see if the cream safely restores color to white patches on the face and body.
Buenos AiresAges 6–11 - NCT07204912Recruiting
Testing a brain-controlled leg prosthesis in real-world tasks
This trial tests a new powered leg prosthesis that you control with your own neural signals. It aims to help people with above-knee amputations walk more naturally in everyday situations.
Cambridge, MassachusettsAges 18–70 - NCT07203417Recruiting
Online program for couples with different sex drives
This study tests an online education program for couples who feel they have different levels of sexual desire, and it causes at least one partner distress. The goal is to see if the program helps improve relationship satisfaction.
Vancouver, British ColumbiaAges 19 years+ - NCT04812730Recruiting
Study of spinal alignment in adults with posture problems
This study measures how your spine and pelvis line up in everyday standing and walking, using multiple types of measurements. It aims to better understand adult spinal deformity and how it affects body mechanics—information that may help plan future care.
Leuven, Vlaams-BrabantAges 18–79 - NCT05560477RecruitingPhase 1/Phase 2
Study drug to help meniscus tears heal after knee injury
This early-phase study tests whether AM3101 can improve healing of a meniscus tear in the knee. Participants must meet age, scan, and health-lab requirements, and they will be closely followed during recovery to check safety and benefit.
Cincinnati, OhioAges 18–40 - NCT07198139RecruitingPhase 1/Phase 2
Testing a new norovirus treatment in healthy adults
This trial tests an investigational medicine called CDI-988 to see if it can prevent or treat norovirus infection. Healthy adults will be intentionally exposed to a mild norovirus strain to see how the medicine works.
Decatur, GeorgiaAges 18–49 - NCT07198659RecruitingEarly Phase 1
New immune cell therapy for advanced pancreatic cancer
This trial tests a new treatment using your own immune cells (called neutrophils) that are loaded with a drug to fight pancreatic cancer that cannot be removed by surgery. It may be an option if standard treatments have stopped working or caused bad side effects.
Xi’an, ShanxiAges 18–70 - NCT07197099Recruiting
Plasma exchange for immune-related nerve diseases
This study looks at whether removing and replacing blood plasma (called therapeutic plasma exchange or TPE) can help people with immune-related nerve or brain conditions. It includes both new and returning cases that meet standard guidelines for this treatment.
CairoAges Any age
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.